Adam Logal
CIK 1356197 · Sr. Vice President, CFO · last filed 2026-07-28
Adam Logal is a Sr. Vice President, CFO who has filed 40 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider had shares withheld for taxes covering $65.0K of OPK on Jul 28, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $929.6K across reported positions. 31 SEC filings were submitted jointly with OPKO HEALTH, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OPK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4400 BISCAYNE BLVD.
MIAMI, FL 33137
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPK | Sr. Vice President, CFO | 563,396 | $1.65 | $929.6K | -$2.17M | 28 | 2026-07-28 |
| Xenetic Biosciences, Inc. (XBIOW) Delisted | Director | — | $17.54 | — | $0 | 5 | 2023-12-08 |
| XBIO | Director | — | $1.93 | — | $0 | 2 | 2018-11-30 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 1,250 | $0.07 | $82 | $0 | 4 | 2018-06-18 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-28 | OPK | Tax (F) | −53,266 | -$65.0K | EDGAR |
| 2025-05-29 | OPK | Grant (A) | — | $0 | EDGAR |
| 2024-07-26 | OPK | Grant (A) | +437,500 | $0 | EDGAR |
| 2023-12-08 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | OPK | Grant (A) | — | $0 | EDGAR |
| 2022-12-09 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-09 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-22 | OPK | Grant (A) | — | $0 | EDGAR |
| 2020-12-08 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | OPK | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.